Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer-Reference-Cited by-同舟云学术

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer

Published:2023-11 Issue: Volume:188 Page:109864
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Ong Wee Loon,Davidson Melanie,Cheung Patrick,Chung Hans,Chu William,Detsky Jay,Liu Stanley,Morton Gerard,Szumacher Ewa,Tseng Chia-Lin,Vesprini Danny,Ravi Ananth,McGuffin Merrylee,Zhang Liying,Mamedov Alexandre,Deabreu Andrea,Kulasingham-Poon Meghan,Loblaw Andrew

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference34 articles.

1. A phase 1/2 trial of brief androgen suppression and stereotactic radiation therapy (FASTR) for high-risk prostate cancer;Bauman;Int J Radiat Oncol Biol Phys,2015

2. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy;Qi;Radiother Oncol : J Eur Soc Therap Radiol Oncol,2016

3. Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapy;Elias;Radiother Oncol: J Eur Soc Ther Radiol Oncol,2014

4. Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy;Alayed;Radiother Oncol: J Eur Soc Ther Radiol Oncol,2020

5. Patient and dosimetric predictors of genitourinary and bowel quality of life after prostate SBRT: secondary analysis of a multi-institutional trial;Wang;Int J Radiat Oncol Biol Phys,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Reply to Onal et al;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer;Clinical and Translational Radiation Oncology;2024-03

3. Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”;Radiotherapy and Oncology;2023-12